首页|Chongqing University Cancer Hospital Reports Findings in Lung Cancer (Predicting survival benefits of immune checkpoint inhibitor therapy in lung cancer patient s: a machine learning approach using real-world data)
Chongqing University Cancer Hospital Reports Findings in Lung Cancer (Predicting survival benefits of immune checkpoint inhibitor therapy in lung cancer patient s: a machine learning approach using real-world data)
扫码查看
点击上方二维码区域，可以放大扫码查看
原文链接
NETL
NSTL
By a News Reporter-Staff News Editor at Robotics & Machine Learning Daily News Daily News – New research on Oncology - Lung Cancer is the subject of a report. According to news reporting originating in Chongqin g, People’s Republic of China, by NewsRx journalists, research stated, “Due to t he heterogeneity in the effectiveness of immunotherapy for lung cancer, identify ing predictors is crucial. This study aimed to develop a machine learning model to identify predictors of overall survival in lung cancer patients treated with immune checkpoint inhibitors (ICIs).”
ChongqingPeople’s Republic of ChinaA siaCancerCy-borgsEmerging TechnologiesHealth and MedicineLung CancerL ung Diseases and ConditionsLung NeoplasmsMachine LearningOncologyTherapy
NETL
NSTL
